These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8017769)

  • 21. Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases.
    Langford-Smith KJ; Mercer J; Petty J; Tylee K; Church H; Roberts J; Moss G; Jones S; Wynn R; Wraith JE; Bigger BW
    J Inherit Metab Dis; 2011 Apr; 34(2):499-508. PubMed ID: 21170681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.
    Mascellani G; Liverani L; Parma B; Bergonzini G; Bianchini P
    Thromb Res; 1996 Oct; 84(1):21-32. PubMed ID: 8885144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin-HCII complex.
    Maekawa H; Sato H; Tollefsen DM
    Thromb Res; 2000 Dec; 100(5):443-51. PubMed ID: 11150588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfated polysaccharide from the leaves of Artemisia Princeps activates heparin cofactor II independently of the Lys173 and Arg189 residues of heparin cofactor II.
    Hayashi T; Hayakawa Y; Hayashi T; Sasaki H; Sakuragawa N
    Thromb Res; 1997 Jul; 87(1):105-12. PubMed ID: 9253805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of heparin cofactor II by dermatan sulfate.
    Tollefsen DM; Pestka CA; Monafo WJ
    J Biol Chem; 1983 Jun; 258(11):6713-6. PubMed ID: 6687888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II.
    Cooper ST; Rezaie AR; Esmon CT; Church FC
    Thromb Res; 2002 Jul; 107(1-2):67-73. PubMed ID: 12413592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin.
    Liaw PC; Becker DL; Stafford AR; Fredenburgh JC; Weitz JI
    J Biol Chem; 2001 Jun; 276(24):20959-65. PubMed ID: 11294849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino acid residues of heparin cofactor II required for stimulation of thrombin inhibition by sulphated polyanions.
    Colwell NS; Grupe MJ; Tollefsen DM
    Biochim Biophys Acta; 1999 Apr; 1431(1):148-56. PubMed ID: 10209287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serpin-glycosaminoglycan interactions.
    Rein CM; Desai UR; Church FC
    Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate.
    Blinder MA; Andersson TR; Abildgaard U; Tollefsen DM
    J Biol Chem; 1989 Mar; 264(9):5128-33. PubMed ID: 2647747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of lysine 173 in heparin binding to heparin cofactor II.
    Whinna HC; Blinder MA; Szewczyk M; Tollefsen DM; Church FC
    J Biol Chem; 1991 May; 266(13):8129-35. PubMed ID: 1902471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant dermatan sulfate is a potent activator of heparin cofactor II-dependent inhibition of thrombin.
    Tykesson E; Maccarana M; Thorsson H; Liu J; Malmström A; Ellervik U; Westergren-Thorsson G
    Glycobiology; 2019 Jun; 29(6):446-451. PubMed ID: 30869126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins.
    Petzelbauer E; Seiffert D; Beckmann R; Pusch B; Geiger M; Binder BR
    Thromb Res; 1992 Jun; 66(5):559-67. PubMed ID: 1381850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II.
    Tollefsen DM; Peacock ME; Monafo WJ
    J Biol Chem; 1986 Jul; 261(19):8854-8. PubMed ID: 3755134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of heparin cofactor II anticoagulant activity.
    Bauman SJ; Church FC
    J Biol Chem; 1999 Dec; 274(49):34556-65. PubMed ID: 10574918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II.
    Shirk RA; Church FC; Wagner WD
    Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1138-46. PubMed ID: 8792767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of activation of heparin cofactor II by calcium spirulan.
    Hayakawa Y; Hirashima Y; Yamamoto H; Kurimoto M; Hayashi T; Lee JB; Endo S
    Arch Biochem Biophys; 2003 Aug; 416(1):47-52. PubMed ID: 12859981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin.
    Holland CA; Henry AT; Whinna HC; Church FC
    FEBS Lett; 2000 Nov; 484(2):87-91. PubMed ID: 11068038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of thrombin by sulfated polysaccharides isolated from green algae.
    Hayakawa Y; Hayashi T; Lee J; Srisomporn P; Maeda M; Ozawa T; Sakuragawa N
    Biochim Biophys Acta; 2000 Nov; 1543(1):86-94. PubMed ID: 11087944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin facilitates dissociation of complexes between thrombin and a reactive site mutant (L444R) of heparin cofactor II.
    Han JH; Van Deerlin VM; Tollefsen DM
    J Biol Chem; 1997 Mar; 272(13):8243-9. PubMed ID: 9079643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.